Disease-Adaptive Drug Delivery to the Inflamed Intestinal Mucosa Using Poly(Lactic-Co-Glycolic Acid)-cyclodextrin Hybrid NanocarriersADVANCED THERAPEUTICSIF2.62025-01-190OAAI
Chemogenomic Screening in a Patient-Derived 3D Fatty Liver Disease Model Reveals the CHRM1-TRPM8 Axis as a Novel Module for Targeted InterventionADVANCED SCIENCEIF14.12024-11-280OAAI
Predicting nanocarrier permeation across the human intestine in vitro: model mattersBIOMATERIALS SCIENCEIF5.72024-01-010OA
Influence of drug molecular weight on self-assembly and intestinal permeation of polymer-based nanocarriersINTERNATIONAL JOURNAL OF PHARMACEUTICSIF5.22023-11-011PRE
Engineered Self-Assembly of Amphiphilic Cyclodextrin Conjugates for Drug EncapsulationACS BIOMATERIALS SCIENCE & ENGINEERINGIF5.52022-12-234PRE
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向